ASPIRA SYNERGY Trademark

Trademark Overview


On Friday, January 29, 2021, a trademark application was filed for ASPIRA SYNERGY with the United States Patent and Trademark Office. The USPTO has given the ASPIRA SYNERGY trademark a serial number of 90498295. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, June 13, 2024. This trademark is owned by Aspira Women's Health, Inc.. The ASPIRA SYNERGY trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; Medical information services, namely, reporting of consumer authorized clinical testing results for clinical review; Providing medical information to doctors and patients in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; Medical analysis services for the diagnosis of cancer; Providing medical information, consultancy and advisory services in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; DNA screening for medical purposes; Medical diagnosis of cancer; Medical diagnosis of ovarian cancer; Medical diagnosis of breast cancer; Medical diagnosis of endometriosis; Genetic testing for medical purposes
aspira synergy

General Information


Serial Number90498295
Word MarkASPIRA SYNERGY
Filing DateFriday, January 29, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, June 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements


Translation of Words in MarkThe English translation of the word ASPIRA in the mark is aspires
Goods and ServicesMedical testing for diagnostic or treatment purposes in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; Medical information services, namely, reporting of consumer authorized clinical testing results for clinical review; Providing medical information to doctors and patients in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; Medical analysis services for the diagnosis of cancer; Providing medical information, consultancy and advisory services in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; DNA screening for medical purposes; Medical diagnosis of cancer; Medical diagnosis of ovarian cancer; Medical diagnosis of breast cancer; Medical diagnosis of endometriosis; Genetic testing for medical purposes

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, May 2, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAspira Women's Health, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 78738

Party NameAspira Women's Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78738

Trademark Events


Event DateEvent Description
Tuesday, February 2, 2021NEW APPLICATION ENTERED
Sunday, May 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 18, 2021ASSIGNED TO EXAMINER
Thursday, August 19, 2021NON-FINAL ACTION WRITTEN
Thursday, August 19, 2021NON-FINAL ACTION E-MAILED
Thursday, August 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 16, 2022SUSPENSION LETTER WRITTEN
Wednesday, February 16, 2022CORRESPONDENCE E-MAILED
Tuesday, August 23, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, September 20, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 20, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, September 20, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 20, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, September 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 7, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 7, 2023SOU EXTENSION 1 FILED
Wednesday, June 7, 2023SOU EXTENSION 1 GRANTED
Friday, June 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, December 18, 2023SOU EXTENSION 2 FILED
Monday, December 18, 2023SOU EXTENSION 2 GRANTED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU EXTENSION 3 FILED
Thursday, June 13, 2024SOU EXTENSION 3 GRANTED